Top 5 Pharmacy Times Oncology Articles of 2023

1. CRISPR Technology Has Cured Patients of Certain Genetic Diseases, But Not All Patients Can Receive It Due to Cost, Accessibility

CRISPR technology has also been successful in treating a pediatric patient with T-cell acute lymphoblastic leukemia, showing feasibility of its use for cancer immunotherapy. Read More Here.

joyfotoliakid - stock.adobe.com

2. Monotherapy Pembrolizumab Demonstrates Historic Response for Rare Skin Cancer

The treatment from Merck shows a clinical response of 89% for individuals with unresectable metastatic desmoplastic melanoma. Read More Here.

3. ‘Warm’ Autopsy Suggests Metastatic Melanoma Has Different DNA Landscape Than Early-Stage Disease

Findings may offer insight into new strategies to tackle skin cancer in patients already treated with a prior line of therapy. Read More Here.

4. FDA to Review sBLA For Idecabtagene Vicleucel in the Early Treatment of Adult Patients with RRMM

The review comes after phase 3 trial results that indicate an improvement in overall survival and progression-free survival, reducing the risk of disease progression and death. Read More Here.

5. Cilta-Cel Shows Long-Term Efficacy in Patients With Relapsed/Refractory Multiple Myeloma

A single infusion of ciltacabtagene autoleucel produced a lower risk of death and disease progression, as well as deep and durable responses, in heavily pretreated patients with relapsed/refractory multiple myeloma. Read More Here.